165 related articles for article (PubMed ID: 30135189)
21. Altered oncomodules underlie chromatin regulatory factors driver mutations.
Frigola J; Iturbide A; Lopez-Bigas N; Peiro S; Gonzalez-Perez A
Oncotarget; 2016 May; 7(21):30748-59. PubMed ID: 27095575
[TBL] [Abstract][Full Text] [Related]
22. Topological network analysis of differentially expressed genes in cancer cells with acquired gefitinib resistance.
Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Kwon K; Jang CS; Noh YH; Kim SY
Cancer Genomics Proteomics; 2015; 12(3):153-66. PubMed ID: 25977174
[TBL] [Abstract][Full Text] [Related]
23. The mRNA related ceRNA-ceRNA landscape and significance across 20 major cancer types.
Xu J; Li Y; Lu J; Pan T; Ding N; Wang Z; Shao T; Zhang J; Wang L; Li X
Nucleic Acids Res; 2015 Sep; 43(17):8169-82. PubMed ID: 26304537
[TBL] [Abstract][Full Text] [Related]
24. Pan-phylum Comparison of Nematode Metabolic Potential.
Tyagi R; Rosa BA; Lewis WG; Mitreva M
PLoS Negl Trop Dis; 2015 May; 9(5):e0003788. PubMed ID: 26000881
[TBL] [Abstract][Full Text] [Related]
25. Multiscale network modeling reveals the gene regulatory landscape driving cancer prognosis in 32 cancer types.
Xu P; Zhang B
Genome Res; 2023 Oct; 33(10):1806-1817. PubMed ID: 37907329
[TBL] [Abstract][Full Text] [Related]
26. Transcriptome Analysis of Recurrently Deregulated Genes across Multiple Cancers Identifies New Pan-Cancer Biomarkers.
Kaczkowski B; Tanaka Y; Kawaji H; Sandelin A; Andersson R; Itoh M; Lassmann T; Hayashizaki Y; Carninci P; Forrest AR;
Cancer Res; 2016 Jan; 76(2):216-26. PubMed ID: 26552699
[TBL] [Abstract][Full Text] [Related]
27. Metabolic profiling of cancer cells reveals genome-wide crosstalk between transcriptional regulators and metabolism.
Ortmayr K; Dubuis S; Zampieri M
Nat Commun; 2019 Apr; 10(1):1841. PubMed ID: 31015463
[TBL] [Abstract][Full Text] [Related]
28. Pan-cancer analysis of somatic mutations and transcriptomes reveals common functional gene clusters shared by multiple cancer types.
Kim H; Kim YM
Sci Rep; 2018 Apr; 8(1):6041. PubMed ID: 29662161
[TBL] [Abstract][Full Text] [Related]
29. TP53 mutations, expression and interaction networks in human cancers.
Wang X; Sun Q
Oncotarget; 2017 Jan; 8(1):624-643. PubMed ID: 27880943
[TBL] [Abstract][Full Text] [Related]
30. Identifying gene modules of thyroid cancer associated with pathological stage by weighted gene co-expression network analysis.
Tang X; Huang X; Wang D; Yan R; Lu F; Cheng C; Li Y; Xu J
Gene; 2019 Jul; 704():142-148. PubMed ID: 30965127
[TBL] [Abstract][Full Text] [Related]
31. Large-Scale Differential Gene Expression Transcriptomic Analysis Identifies a Metabolic Signature Shared by All Cancer Cells.
Rmaileh AA; Solaimuthu B; Tanna M; Khatib A; Yosef MB; Hayashi A; Lichtenstein M; Shaul YD
Biomolecules; 2020 Apr; 10(5):. PubMed ID: 32365991
[TBL] [Abstract][Full Text] [Related]
32. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
Hachim IY; Shams A; Lebrun JJ; Ali S
Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
[TBL] [Abstract][Full Text] [Related]
33. Integrating mutation and gene expression cross-sectional data to infer cancer progression.
Fleck JL; Pavel AB; Cassandras CG
BMC Syst Biol; 2016 Jan; 10():12. PubMed ID: 26810975
[TBL] [Abstract][Full Text] [Related]
34. A genomic strategy to elucidate modules of oncogenic pathway signaling networks.
Chang JT; Carvalho C; Mori S; Bild AH; Gatza ML; Wang Q; Lucas JE; Potti A; Febbo PG; West M; Nevins JR
Mol Cell; 2009 Apr; 34(1):104-14. PubMed ID: 19362539
[TBL] [Abstract][Full Text] [Related]
35. Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas.
Rosario SR; Long MD; Affronti HC; Rowsam AM; Eng KH; Smiraglia DJ
Nat Commun; 2018 Dec; 9(1):5330. PubMed ID: 30552315
[TBL] [Abstract][Full Text] [Related]
36. Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cells.
Ray U; Roy Chowdhury S; Vasudevan M; Bankar K; Roychoudhury S; Roy SS
Mol Oncol; 2017 May; 11(5):491-516. PubMed ID: 28236660
[TBL] [Abstract][Full Text] [Related]
37. Conservation of immune gene signatures in solid tumors and prognostic implications.
Chifman J; Pullikuth A; Chou JW; Bedognetti D; Miller LD
BMC Cancer; 2016 Nov; 16(1):911. PubMed ID: 27871313
[TBL] [Abstract][Full Text] [Related]
38. Co-expression modules construction by WGCNA and identify potential prognostic markers of uveal melanoma.
Wan Q; Tang J; Han Y; Wang D
Exp Eye Res; 2018 Jan; 166():13-20. PubMed ID: 29031853
[TBL] [Abstract][Full Text] [Related]
39. Metabolic gene alterations impact the clinical aggressiveness and drug responses of 32 human cancers.
Sinkala M; Mulder N; Patrick Martin D
Commun Biol; 2019; 2():414. PubMed ID: 31754644
[TBL] [Abstract][Full Text] [Related]
40. A network-pathway based module identification for predicting the prognosis of ovarian cancer patients.
Wang X; Wang SS; Zhou L; Yu L; Zhang LM
J Ovarian Res; 2016 Nov; 9(1):73. PubMed ID: 27806724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
